See All Slides - tctmd.com

Slides

Presentation Cell Therapy 2013

Adipose-Derived Regenerative Cells in Chronic Ischemic Heart Disease

Presenter: Emerson C. Perin

January 22, 2013

Presentation Cell Therapy 2013

BMAC for CLI: Status of a Phase 3 Trial

Presenter: Amit Patel

January 22, 2013

Presentation Cell Therapy 2013

SDF-1: Final Results of a Phase 1 Trial and Status of STOP-HF Study

Presenter: Marc S. Penn

January 22, 2013

Presentation Cell Therapy 2013

CD-34+ Cells for Ischemic Heart Failure

Presenter: Bojan Vrtovec

January 22, 2013

Presentation Cell Therapy 2013

EXCELLENT Trial Design

Presenter: J?r?me Roncalli

January 22, 2013

Presentation Cell Therapy 2013

A Phase 2 Pilot Study to Evaluate the Safety and Activity of BB3 as an Adjunct to PCI in Subjects Presenting with STEMI

Presenter: Frank J. Giordano

January 22, 2013

Presentation Cell Therapy 2013

IK 5001 - A Novel Approach to Myocardial Remodeling

Presenter: David F. Kong

January 22, 2013

Presentation Cell Therapy 2013

Clinical Outcomes and Surrogate Efficacy Data for a Phase II Dose-Escalation Study of Allogeneic Mesenchymal Precursor Cells

Presenter: Kenneth Borow

January 22, 2013

Presentation

Stent Thrombosis: Predisposing Factors and How to Prevent

Presenter: Ajay J. Kirtane

January 21, 2013

Presentation

Rheolytic Thrombectomy for Deep Vein Thrombosis: Prospective Multicenter Registry Report

Presenter: Robert A. Lookstein

January 21, 2013

Advertisement

Slides

Adipose-Derived Regenerative Cells in Chronic Ischemic Heart Disease

BMAC for CLI: Status of a Phase 3 Trial

SDF-1: Final Results of a Phase 1 Trial and Status of STOP-HF Study

CD-34+ Cells for Ischemic Heart Failure

EXCELLENT Trial Design

A Phase 2 Pilot Study to Evaluate the Safety and Activity of BB3 as an Adjunct to PCI in Subjects Presenting with STEMI

IK 5001 - A Novel Approach to Myocardial Remodeling

Clinical Outcomes and Surrogate Efficacy Data for a Phase II Dose-Escalation Study of Allogeneic Mesenchymal Precursor Cells

Stent Thrombosis: Predisposing Factors and How to Prevent

Rheolytic Thrombectomy for Deep Vein Thrombosis: Prospective Multicenter Registry Report

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content